Feng Jinzhou
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders (NCT06118398) | Feng Jinzhou | 2023-11-05 |
| Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders (NCT06068829) | Feng Jinzhou | 2023-10-20 |
Track Feng Jinzhou automatically
Every clearance here is in the API, with alerts when new ones post.